The most frequently mutated genes, in agreement with other large AML studies [12, 13], were FLT3 (33% of subjects), NPM1 (32%), NRAS (30%), and DNMT3A (25%) (Fig. 1). This evidence concerns the gene DNMT3A and acute myeloid leukemia.